Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCN-01 + Topotecan in Advanced Ovarian Cancer
NCT00072267Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jan 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 7-hydroxystaurosporine in ovarian cancer, primary peritoneal cancer (PPC) and fallopian tube cancer (PFTC), sponsored by University Health Network. Primary endpoint: Objective Response Rate. Started Jan 2004; status: completed.
02
Drugs
7-hydroxystaurosporine
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00072267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00072267.